IQ EQ FUND MANAGEMENT (IRELAND) Ltd

Position in NTLA — Intellia Therapeutics, Inc.

CIK 1620943 DUBLIN 2, L2

Position in NTLA

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$9,285,346

+$2,709,872 QoQ

Shares Held

724,286

-1.0% QoQ

Ownership

0.518%

of shares outstanding

% of Portfolio

0.72%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

IQ EQ FUND MANAGEMENT (IRELAND) Ltd holds $54,956,129 across 12 Biotechnology names. NTLA ranks #3 (16.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CRSP	CRISPR Therapeutics AG	400,877	$19,069,718
2	BEAM	Beam Therapeutics Inc.	488,417	$11,638,977
3	NTLA	Intellia Therapeutics, Inc. This page	724,286	$9,285,346
4	RXRX	Recursion Pharmaceuticals, Inc.	2,557,403	$7,851,227
5	ABSI	Absci Corp	541,182	$1,623,546
6	NRIX	Nurix Therapeutics, Inc.	81,760	$1,267,280
7	IONS	Ionis Pharmaceuticals Inc	14,389	$1,080,470
8	ARCT	Arcturus Therapeutics Holdings Inc.	114,255	$882,048

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$9,285,346	724,286	-1.0%	Shares	Sole	2026-05-11
2025-12-31	$6,575,474	731,421	+47.9%	Shares	Sole	2026-02-12
2025-09-30	$8,539,462	494,468	+68.0%	Shares	Sole	2025-11-05
2025-06-30	$2,761,350	294,387	+177.2%	Shares	Sole	2025-08-01
2025-03-31	$755,145	106,209	+94.3%	Shares	Sole	2025-05-09
2024-12-31	$637,300	54,657	+137.3%	Shares	Sole	2025-02-12
2024-09-30	$473,287	23,031	+75.2%	Shares	Sole	2024-10-16
2024-06-30	$294,117	13,142	—	Shares	Sole	2024-07-29
No filing history on record for this holder in this stock.